Beyond Compliance: The Strategic Value of Independent External 340B Audits

The 340B Drug Pricing Program is more than a pharmacy benefit; it is a lifeline for vulnerable communities and patients. However, as federal scrutiny and manufacturer challenges intensify, maintaining program […]
Read More










